These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2461052
1. Differential expression of c-myc and c-fos oncogenes during the differentiation of human leukemic cells by Ara-C. Chomienne C, Emanoil-Ravier R, Balitrand N, Garcette M, Degos L, Abita JP. J Biol Regul Homeost Agents; 1987; 1(2):69-72. PubMed ID: 2461052 [Abstract] [Full Text] [Related]
2. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD. Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [Abstract] [Full Text] [Related]
3. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells. Mitchell T, Sariban E, Kufe D. Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806 [Abstract] [Full Text] [Related]
4. [Low-dose recombinant human tumor necrosis-alpha in HL-60 leukemic cell line: effect on induced differentiation and regulating expression of c-myc, c-fos proto-oncogenes]. Yuan YC, Shen SY. Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):666-9, 708-9. PubMed ID: 7866900 [Abstract] [Full Text] [Related]
5. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation. Sariban E, Mitchell T, Griffin J, Kufe DW. J Immunol; 1987 Mar 15; 138(6):1954-8. PubMed ID: 3102606 [Abstract] [Full Text] [Related]
6. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase. Yamamoto-Yamaguchi Y, Makishima M, Kanatani Y, Kasukabe T, Honma Y. Exp Hematol; 1996 May 15; 24(6):682-9. PubMed ID: 8635523 [Abstract] [Full Text] [Related]
7. Molecular events induced in the HL 60 cell line following treatment with gamma-interferon. Dubreuil P, Courcoul M, Mannoni P. Cancer Detect Prev; 1988 May 15; 12(1-6):15-21. PubMed ID: 3141051 [Abstract] [Full Text] [Related]
8. Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells. Datta R, Kharbanda S, Kufe D. Mol Pharmacol; 1990 Oct 15; 38(4):435-9. PubMed ID: 2122229 [Abstract] [Full Text] [Related]
9. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD. Oncol Res; 1994 Oct 15; 6(2):87-99. PubMed ID: 7949469 [Abstract] [Full Text] [Related]
10. Inhibition of DNA synthesis by an inducer of differentiation of leukemic cells, 1 alpha, 25 dihydroxy vitamin D3, precedes down regulation of the c-myc gene. Brelvi ZS, Studzinski GP. J Cell Physiol; 1986 Aug 15; 128(2):171-9. PubMed ID: 3755442 [Abstract] [Full Text] [Related]
11. Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cells. Brach MA, Riedel D, Mertelsmann RH, Herrmann F. Leukemia; 1990 Sep 15; 4(9):646-9. PubMed ID: 2144331 [Abstract] [Full Text] [Related]
12. Changes in c-myc, c-fms, and N-ras proto-oncogene expression associated with retinoic acid-induced monocytic differentiation of human leukemia HL60/MRI cells. Imaizumi M, Breitman TR. Cancer Res; 1988 Dec 01; 48(23):6733-8. PubMed ID: 3180083 [Abstract] [Full Text] [Related]
13. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD. Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972 [Abstract] [Full Text] [Related]
14. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias. Shiosaka T, Tanaka Y. Anticancer Res; 1989 Oct 10; 9(5):1249-64. PubMed ID: 2589822 [Abstract] [Full Text] [Related]
15. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine. Datta R, Kharbanda S, Kufe DW. Mol Pharmacol; 1992 Jan 10; 41(1):64-8. PubMed ID: 1732724 [Abstract] [Full Text] [Related]
16. [Comparison of the sensitivity of retinoic acid sensitive and resistant HL-60 cell lines to several anti-leukemia drugs]. Li L, Xia L, Han R. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Dec 10; 16(6):469-72. PubMed ID: 7720148 [Abstract] [Full Text] [Related]
17. [Combination induction of cell differentiation of HL-60 cells by daidzein (S86019) and BC-4 or Ara-C]. Jing YK, Han R. Yao Xue Xue Bao; 1993 Dec 10; 28(1):11-6. PubMed ID: 8328263 [Abstract] [Full Text] [Related]
18. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation. Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW. Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907 [Abstract] [Full Text] [Related]